Article
Identification of FtfL as a novel target of berberine in intestinal bacteria
5 Dec 2023
Abstract excerpt
BACKGROUND: Berberine (BBR) is a commonly used anti-intestinal inflammation drug, and its anti-cancer activity has been found recently. BBR can intervene and control malignant colorectal cancer (CRC) through intestinal microbes, but the direct molecular target and related mechanism are unclear. This study aimed to identify the target of BBR and dissect related mechanisms against the occurrence and development of...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
